In the CRISPR-Cas systems, Cas13a is an RNA-guided RNA nuclease specifically targeting single strand RNA. In this study we developed a Cas13a mediated CRISPR interference tool to target mRNA for gene silencing in mosquitoes and tested the machinery in two mosquito species. A Cas13a expressing plasmid was delivered to mosquitoes by intrathoracic injection, and Cas13a transcripts were detectable at least 10 days postdelivery. In Anopheles gambiae, vitellogenin (Vg) gene was silenced by Vg-crRNA injection two hours post blood meal, which was accompanied by a significant reduction in egg production. In Aedes aegypti, the αand δ -subunits of COPI genes were knocked down by a post-blood meal crRNA injection, which resulted in mortality and fragile midguts, reproducing a phenotype reported in a RNAi mediated COPI gene silencing study. The silencing of mulitple genes simlutaneously is achievable when mosquitoes are given a cocktail of Cas13a construct with crRNAs targeting respective genes. This study adds a programable CRISPR tool to manipulate RNA in insects.
Introduction
In the post-genomic era, mosquito studies have been greatly accelerated by the integration of functional genomics approaches. The genetic basis for various mosquito life traits are being characterized and can inform innovative control strategies through the identification of genes involved in development, host-seeking, blood feeding, digestion, fecundity, immunity against various pathogens, xenobiotic metabolism and insecticide resistance. With increased insecticide resistance, the tool box for vector control is needing new tools to combat these insect vectors of significant human disease.
RNA interference (RNAi) is a defense mechanism that eukaryotic organisms use to target invading RNA viruses. RNAi based approaches have been widely used in gene function study to identify genes that are relevant to vector competence, and recently has been developed into effectors for mosquito control [1] [2] [3] [4] [5] . The RNAi machinery consists of Dicer and RNA-inducible silencing complex (RISC). The machinery is trigged by double-stranded RNA (dsRNA), which can be recognized by Dicer and cleaved into small interfering RNAs (siRNAs). Guided by siRNA, the nuclease Argonaut in the RISC complex cleaves target mRNA to silence the gene. CRISPR-Cas systems are adaptive immune mechanisms prokaryotes use to fight against invading DNA and RNA [6] [7] [8] [9] . Cas9 is a RNA guided DNA nuclease and once assembled with a CRISPR guide RNA (sgRNA), the Cas9 is able to cleave target DNA specifically. The DNA-targeting Cas9 has been harnessed for genome editing 10, 11 . Recently, CRISPR-Cas9 based genome editing tools have been developed in the mosquito research field [12] [13] [14] . Alternatively, catalytically inactive Cas9 (dCas9) was adopted for manipulation of gene expression. The dCas9 can be fused with a gene repressor or transcription activator. Guided by CRISPR RNA, such variants are able to bind target promoter or exonic DNA sequence without cleavage, and either repress transcription (CRISPR interference, CRISPRi) or activate transcription of target genes (CRISPR activation, CRISPRa) 15 8, 23 . In bacteria, Cas13 HEPN-nuclease is able to cleave not only the target-RNA in cis but also other non-target RNA present in trans. Interestingly, no collateral effect was observed in three studies of CRISPR-Cas13 using human or plant cell lines 8, 23, 24 , but Cas13a associated collateral RNA cleavage was reported in human glioma cancer cells 25 . Fascinatingly, Cas13 can effectively silence serval transcripts in parallel 8, 18, 24, 26 . Taken together, CRISPR-Cas13 systems have become a new exciting version of CRISPRi 27 . In this study, we engineered a construct to express Cas13a from Leptotrichia wadei in mosquitoes, and demonstrated its efficacy in silencing genes in mosquito Anopheles gambiae and Aedes aegypti.
Materials and Methods

Plasmid construction
The Cas13a gene from L. wadei belongs to the class 2 type VI RNA-guided RNA nuclease 8 . It's RNA targeting effect has been demonstrated in eukaryotic and plant cells 8, 18, 25, 28 . Plasmid pAc-sgRNA-Cas9 was used as a template to engineer construct pAc-Cas13a ( Fig. 1) . Plasmid pAc-sgRNA-Cas9 was a gift from Ji-Long Liu (Addgene plasmid # 49330). The codons of LwaCas13a gene were optimized to Drosophila preference. The codon optimized Cas13a sequence was synthesized and cloned at GenScript 
Synthesis of crRNA
A crRNA consists of a 36-nt repeat sequence and 28-nt target RNA specific sequence (N28), which is an anti-sense sequence complementary to the target RNA sequence. T7 promoter sequence was added to the 5' end to enable crRNA synthesis using T7 RNA polymerase in vitro.
The crRNA template is AGTTAATACGACTCACTATAGGGATTTAGACTACCCCAA AAACGAAGGGGACTAAAAC(N28). The target specific sequences (N28) used in this study are shown in Table 1 . The selection of crRNA is straightforward, LwaCas13a does not require PFS for activity 8 , which makes no limitation to choose a crRNA in a target gene. For each target gene (except for Vg, which had only one crRNA), two specific N28 sequences were designed and used together for gene silencing. Template DNA duplex of the crRNAs were synthesized at IDT Inc. An. gambiae G3 strain and Ae. aegypti Puerto Rico strain were obtained from MR4 BEI and maintained using rearing conditions described previously 29, 30 . The pAc-Cas13a construct (0.5g/l) was delivered into one-day old female mosquitoes by intrathoracic injection. To aid construct delivery into the cell, the construct was mixed with a transfecting agent FuGENE HD (E2311, Promega) at concentration of 1.6l of FuGENE reagent with 10g construct DNA in 20
l. Gene specific crRNAs were either delivered with the construct or separately at a later time point. For blood inducible genes, Vg and COPI, female mosquitoes were given a blood meal three days post construct injection. The corresponding crRNAs (0.5g/l, prepared in FuGENE as described above) were injected into mosquito hemocoel at two hours post blood meal.
RNA isolation, cDNA synthesis and PCR
Total RNA was isolated using Trizol (Invitrogen) following the manufacturer's instruction.
The RNA was treated with Turbo DNase I Kit to remove genomic DNA contamination, and then 1g RNA was converted to cDNA using Protoscript II RT (M0368S, New England Biolabs)
following the manufacturer's instruction. The PCR assays were performed using 1l 1:5 diluted cDNA as template, 0.2 M primers (primer sequences are presented in Table S1 ) and 2 × PCR Master mix (M0482S, NEB), with the following cycling parameters: 35 cycles of denaturing at 95°C for 15 seconds, annealing at a temperature optimal for the amplicon (Table S1 ) for 15 seconds, and extension at 68°C for 20 seconds with an extra 5 min in the last cycle for final extension.
Statistical analysis
In the gene Vg knockdown experiment, eggs were dissected from ovaries at day 3 post blood meal. The egg counts were compared between the Vg crRNA and control crRNA cohorts.
The non-parametric Mann-Whitney test was used for statistical comparison of the egg numbers.
In the COPI gene knockdown experiment, a survival curve was plotted, and Mantel-Cox analysis was performed to compare the survival between the COPI crRNA and control crRNA cohorts using GraphPad Prism.
Results
Cas13a expression in mosquitoes post intrathoracic delivery
A construct was engineered to express Cas13a gene by modifying the plasmid pAc-sgRNA-Cas9, which was successfully used to transfect Drosophila cells for targeted genetic mutagenesis 31 . As shown in Fig. 1, Cas13a coding sequence is under the control of constitutive promoter Actin 5C. To deliver the construct to mosquito hemocoel, the plasmid was prepared with transfection reagent FuGENE HD and injected into thorax. We examined Cas13a transcription by RT-PCR in mosquitoes after receiving the construct. In An. gambiae, Cas13a transcripts were detected at three days post construct injection ( Fig. 2A) . No non-specific amplifications were observed in the controls that did not receive the construct. In Ae. aegypti, the construct was delivered to one-day old mosquitoes, and the Cas13a transcripts were detected on day 2, 5, 7 and 10 post construct delivery (Fig. 2B) .
Cas13a mediated Vitellogenin gene silencing in An. gambiae
In mosquitoes, yolk protein precursor vitellogenins (Vg) are required for the vitellogenic stage in oogenesis after blood feeding 32 . To test Cas13a/crRNA mediated Vg silencing, the Cas13a
construct was delivered to one-day old An. gambiae (N = 120). Three days later, the mosquitoes were given a blood meal to induce Vg expression (N = 96). To activate Vg knockdown, Vg crRNA (N = 41) or control crRNA (N = 40) were injected into the blood engorged females at 2 hr post feeding. The Vg RT-PCR was used for verification of Vg knockdown. As shown in Fig. 3 , the abundance of Vg transcript was reduced in females that received Vg-crRNA as compared to females that received control-crRNA. As expected, successful Vg knockdown resulted in reduction in egg production. The Vg-crRNA treated mosquitoes produced on average 39 ± 25 eggs/female Fig. S1 ). The Vg proteins are produced by fat body and secreted into hemolymph, and subsequently deposited in developing oocytes via receptor-mediated endocytosis. The results suggest that the Cas13 construct was successfully delivered into fat body cells, where the Cas13a was transcribed and translated into functional Cas13a proteins. Post blood feeding, Vg-crRNAs were delivered into cells, where they were assembled with Cas13a to form a target specific RNA nuclease complex, which cleaved the Vg mRNA effectively.
Cas13a mediated COPI gene silencing in Aedes aegypti
The coatomer complex I (COPI) proteins are involved in blood digestion in Ae. aegypti 33 .
The COPI complex consists of , β, β', , δ, ε and ζ subunits, each encoded by separate genes. The production of COPI proteins is blood inducible between 18-36 hr post blood meal in fat body and 24-48 hr post blood meal in ovaries 33 . The dsRNA mediated knockdown of the genes encoding all but the ε subunit led to blood meal-induced mortality 33 . Therefore, we targeted the COPI genes to test the gene silencing efficacy of the Cas13a machinery in Ae. aegypti. The Cas13a construct was injected into one-day old mosquitoes (N = 90). At day 3 post construct delivery, the mosquitoes were given a blood meal. The engorged mosquitoes (N = 75) were split into two (Fig. 4) . The survival curves over 9 days post blood meal exhibited difference between the COPI knockdown (N = 22) and control cohort (N = 24) (Fig. 4) . The difference was statistically significant as determined by Mantel-Cox test (P<0.001). In the COPI knockdown cohort, mosquitoes continue to exhibit mortality till day 11 with 0% survival as compared to 27% survival in the control cohort. It has previously been shown that COPI knockdown makes midgut fragile 33 .
Consistently, we observed that the midguts in the COPI knockdown mosquitoes were apt to break and leak during dissection, while the midguts of control mosquitoes were in good shape with intact blood bolus (Fig. 4) . These data represent the findings from a single experiment. A second experimental replicate showed a significant reduction in the survival of the COPI knockdown cohort by day 5 (Mantel-Cox test, P<0.01, Fig. S2 ). To determine the potential for silencing multiple genes, a cocktail of the Cas13a construct and crRNA against genes Cactus and Caspar or Cactus and COPI were delivered into Ae. aegypti.
Cas13a mediated double gene knockdown
As expected, the target gene transcripts were reduced effectively by the machinery (Fig. 5 ).
Discussion
In this proof of concept study, we demonstrate the effectiveness of CRISPRi that is mediated by CRISPR-Cas13a/crRNA machinery. The LwaCas13a is derived from L. wadei, and under control of Actin promoter (Fig.1) . The construct is delivered into the hemocoel of adult mosquitoes by intrathoracic injection, and Cas13a is transcribed constitutively (Fig. 2) . Likely, the construct enters into the nucleus where the Cas13a gene is transcribed, and then the mRNA comes into the cytoplasm where the protein is translated. The construct remains active to transcribe
Cas13a for at least 10 days post-delivery (Fig. 2) , which makes it temporally flexibile to administer crRNAs targeting various genes that are expressed at different time points during a mosquito's life span. Target gene specific crRNAs can be delivered either with the construct together, or at a distinct time point as appropriate to the experimental design. The system can silence highly abundant transcripts, as demonstrated by targeting Vg transcripts in An. gambiae (Fig. 3) and COPI transcripts in Ae. aegypti (Fig. 4) . In both cases, the target genes are induced by blood meal with a high transcriptional abundance. In addition, we have tested the system on genes Cactus, Caspar in Ae. aegypti (Fig. 5) . Taken together, these data conclusively demonstrate that the Cas13a-CRISPRi machinery is functional in An. gambiae and Ae. aegypti mosquitoes we tested in this study. This tool may work well in other mosquito species.
The Cas13a-CRISPRi has certain advantages over the dCas9-CRISPRi for repressing gene expression 16, 34 . First, the dCas9-CRISPRi machinery acts at DNA level while Cas13a targets mRNA directly. RNA-guided binding of dCas9 to a specific promoter or coding sequence can block transcription. This mode of action is efficient in bacteria, but not often very efficient in eukaryotic cells 16 . The dCas9 fusion proteins with a repressive domain have been developed for transcriptional repression, such as dCas9-KRAB (Krüppel associated box) in mammalian cells 15 , but it is challenging to develop a fusion dCas9 with universal applicability. In addition, target specific sgRNA selection may be limited by the PAM that is required for the Cas9 activity. On the contrary, no PFS is required for target RNA cleavage by LwaCas13a in eukaryotic cells 21 . The action mode of Cas13 is simple and programable, and the efficacy has proven high in mammalian cells 8, 23 and in mosquitoes in the current study. RNAi mediated gene silencing is a very common practice in mosquito gene function studies. Recently, application versions have been developed for mosquito vector control 4, 5 . In these application cases, dsRNA is used to trigger RNAi machinery. In dsRNA mediated RNAi, the effective siRNA sequences sometimes are difficult to predict, therefore, large dsRNA fragments are often used to increase chances to generate effective siRNA by Dicer. However, this strategy is accompanied with a higher chance to produce siRNA with off-target potentials 35, 36 . In addition, efficacy of dsRNA-RNAi varies in various contexts, optimal outcomes often result from an empirical process 37 .
There is a concern about the potential of collateral cleavage with Cas13a, in which nonspecific RNA sequences can be cleaved by Cas13a in bacteria 8 . Interestingly, this promiscuous RNA degradation activity was not observed in several studies in mammalian and plant cells 8, 23, 24 . These data have warranted its safety to be used as an effector to target against RNA viruses that infect humans 21 . However, a Cas13a/crRNA associated collateral cleavage was shown recently in human cancerous U87 glioblastoma cells 25 . In the study, exogenous gene GFP or EGFRVIII were overexpressed and targeted by Cas13a/crRNA. In this context, a partial degradation of ribosomal RNA was observed, and the abundance of non-target transcripts of GAPDH, HOTHAIR and L3MTL1 was reduced as well 25 . Furthermore, the RNA integrity was compared between the LN229 glioma cell line and HEK293T cells after treatment with the Cas13a/crRNA, the LN229 cells tended to be more sensitive to the collateral effect than the HEK293T cells 25 . In our study, we used genes encoding ribosomal protein rpS5 in An. gambiae and rpS7 in Ae. aegypti as nontarget gene for control; we did not observe reduced abundance of these two control transcripts in the experiments in which the effective Cas13/crRNA target gene silencing occurred ( Fig. 3-5 ).
Although our data showed no effect on those two non-target genes, we could not rule out the possibility of collateral cleavage of other RNAs. Additional studies are required to examine nontarget RNA cleavage by the Cas13/crRNA system in mosquitoes.
The Cas13a-CRISPRi system as a new tool holds promise for robust and flexible programming to silence one or more genes simultaneously in mosquitoes, with potential applications in other arthropods. Ag_rpS5_R CGAAAACCATCCACACACAC Figure S1 . The Vg crRNA/Cas13a treatment significantly reduced egg production in An. gambiae. Mann-Whitney test, P<0.01. 
